Reviewed by WANGYATAO·Last reviewed 2026-11-11·Medical disclaimer

In short

Castleman disease is a rare lymphoproliferation with unicentric and multicentric forms needing tailored, often specialist, therapy.

What this guide covers: Overview · Diagnosis · Unicentric · Multicentric · Prognosis

Overview

Castleman disease is a rare disorder of lymph node tissue with two main forms: unicentric disease, involving a single node region, and multicentric disease, affecting many sites. Testing for HHV8 and HIV helps classify the disease. Idiopathic multicentric Castleman disease is managed differently from infection-associated forms.

Diagnosis

And Workup Evaluation includes a physical exam, blood counts, inflammatory markers, and protein studies. PET/CT imaging and virology testing are part of the standard workup. Doctors rule out conditions that mimic the disease, such as POEMS syndrome, lymphoma, and infection, before confirming the diagnosis.

Unicentric

Disease Localized disease is often treated with complete surgical removal, which can be curative. Unresectable cases may be managed with radiation, embolization, or careful observation.

Multicentric

Disease Multicentric disease requires systemic therapy guided by subtype and severity. Specialists consider HHV8, HIV, and organ function when selecting treatment. Relapsed or refractory cases use alternative regimens, and biopsy is encouraged to exclude transformation to lymphoma.

Prognosis

And Support Outcomes depend on subtype and how the disease responds to therapy. Fertility counseling and supportive care help manage the condition and its treatment effects.

Sources and further reading

One reference to a U.S. government health source (National Institutes of Health or MedlinePlus) for the medical background of this guide. It is context, not a substitute for advice from your treating doctor.

General information for international patients, not medical advice or a diagnosis. Read the medical disclaimer.